Safety and Efficacy of INCB007839 With Trastuzumab and Vinorelbine in Patients With Metastatic HER2+ Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Denise A. Yardley, MD
Sara Cannon Research Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Fayetteville, Arkansas, United States
- Facility name not stated
Duarte, California, United States
- Facility name not stated
Denver, Colorado, United States
- Facility name not stated
Davie, Florida, United States
- Facility name not stated
Jacksonville, Florida, United States
- Facility name not stated
Detroit, Michigan, United States
- Facility name not stated
St Louis, Missouri, United States
- Facility name not stated
Hackensack, New Jersey, United States
- Facility name not stated
Lake Success, New York, United States
- Facility name not stated
Huntersville, North Carolina, United States
- Facility name not stated
Cincinnati, Ohio, United States
- Facility name not stated
Philadelphia, Pennsylvania, United States
- Facility name not stated
Nashville, Tennessee, United States
- Facility name not stated
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2010
- Primary completion
- 30 Sept 2011
- Completion
- 31 Oct 2011
- Last update posted
- 25 Jan 2012
- Registered enrollment
- 20
- Registry id
- NCT01254136
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.